Navigation Links
Hiemstra Appoints Daniel C. Rosenman as Vice President of Research & Development

Furthers firm design and development efforts that focus on usability and

rapid commercialization

SAN FRANCISCO, March 25 /PRNewswire/ -- Hiemstra Product Development, an innovative, product design and development company, serving the life sciences industry, today announced the appointment of Daniel C. Rosenman as Vice President of Research & Development. As the company continues to expand, Dan furthers Hiemstra's commitment to the design and engineering of medical technologies that focus on usability and rapid commercialization.

Dan joins Hiemstra with over 16 years of R&D, operations, clinical, regulatory and quality systems experience in the life sciences industry. He has developed novel medical technologies in diverse clinical areas including general surgery, gynecology, orthopedics, urology, cardiac surgery, interventional cardiology, and ophthalmology, in both large companies and early-stage ventures. He began his life science career as an R&D engineer, specializing in bioabsorbable polymers, with Ethicon, Inc., a Johnson & Johnson company. Dan was one of the early employees at med tech start-ups, Heartport, Inc. and BioCardia, Inc., where he led the R&D efforts from the initial founding, to financing and through commercialization. Dan was the first employee at Transcend Medical, Inc., a venture-backed ophthalmic company. Within months of joining Transcend, he completed research, development and clinical milestones that resulted in series A funding. Dan holds over 27 U.S. patents in the medical field and has other global patents pending. He has co-authored several scientific and clinical publications in collaboration with clinical leaders at Stanford University, Massachusetts General Hospital, and HELIOS Hospital, Siegburg, Germany.

"My passion is to enable clients to develop their novel medical technologies for clinicians and, ultimately, patients," explains Rosenman. "At Hiemstra, our unique product development process delivers that. Our industrial and mechanical design teams are fully-integrated and focused on human factors that result in elegant solutions that go far beyond just clinical utility."

Doug Hiemstra, President, Hiemstra Product Development stated, "Dan adds tremendous value to our company and our customers. He brings a strong track record of successfully moving medical technologies from concept to development through commercialization."

About Hiemstra:

Hiemstra Product Development is an innovative medical product design and development company, serving the life sciences industry. Founded in 1991, this San Francisco-based firm is built on its unparalleled integration of industrial design and development, with a unique focus on usability. The company's production facilities provide for device assembly and rapid commercialization. Hiemstra's veteran team's experience spans a broad range of clinical areas and applications, and clients include start-ups to Fortune 500 companies. A description of services can be found at

SOURCE Hiemstra Product Development
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hiemstra Approved to Manufacture Medical Devices in New CER
2. AMICAS Appoints Joseph D. Hill to Its Board of Directors and Promotes Kevin C. Burns to Senior Vice President and Chief Financial Officer
3. Digirad Corporation Appoints John W. Sayward to Its Board of Directors
4. NutraCea Appoints New Chief Financial Officer
5. Transplant Network Appoints Cynthia Siljestrom CEO
6. Solera Holdings, Inc. Appoints Jason Brady as General Counsel
7. The Childrens Hospital of Philadelphia Appoints New Chief Nursing Officer
8. InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quality Affairs
9. Ventas Appoints James D. Shelton and Robert D. Reed to Board
10. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
11. China Sky One Medical, Inc. Appoints Four Independent Board Members
Post Your Comments:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... will provide scholarships for people struggling with eating disorders as a result of ... the second annual event, held at Fox Run Golf Club in Eureka, will ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development and ... of its current state of the art research, development and manufacturing facility outside ... its manufacturing capacity as well as to support its clients’ growing research and ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Complex (TSC), as well as raising public awareness of the disorder while helping ... a third donation of $35,000 to bolster progress at the Tuberous Sclerosis Complex ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... treatment, is offering lower prices in an early celebration of the early holiday ... promotional price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Todd S. Afferica, a noted ... to many of his patients. Dr. Afferica now uses the BIOLASE WaterLase iPlus 2.0™ ... of time the doctor uses other traditional cutting tools, such as the scalpel and ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 Allergan plc ... an agreement with the New York State ... 2 of the Sherman Act, and other statutes with the ... in February 2014, to cease marketing and selling the now ... of settlement, Allergan admits no liability, has released its counterclaims ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... NEW YORK , November 25, 2015 ... global market of self-monitoring blood glucose devices was valued ... to grow with a CAGR of 5.7% during 2015 ... increasing geriatric population and increasing prevalence of diabetes. In ... about diabetes care is also contributing to the growth ...
Breaking Medicine Technology: